Skip to main
AHCO

AdaptHealth Corp (AHCO) Stock Forecast & Price Target

AdaptHealth Corp (AHCO) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AdaptHealth is in a strong position for future growth with their innovative market leadership within the home medical equipment (HME) industry and their successful onboarding of a new capitated contract, which indicates the potential for additional large-scale partners in the future. Progress within their Sleep Health, Respiratory Health, and Diabetes Health segments, as well as a strong focus on sustainability and social benefit, support a positive outlook for the company's organic growth prospects in 2026 and beyond.

Bears say

AdaptHealth is expected to see strong operating leverage and margin expansion due to its scalable platform and low-cost infrastructure, however potential risks such as disruptions to operations, changes in the competitive landscape, and potential regulatory issues or liabilities could negatively impact their rating and price target. With a focus on fast-growing segments of healthcare distribution, the company also faces challenges from supply chain issues, regulatory and reimbursement changes, and slowing end-markets. Estimates and price target have been lowered, with a future valuation based on a 4.9x forward EV/EBITDA multiple. Investors should also be aware of potential risks involving external growth, internal processes, and budget deficit-related issues.

AdaptHealth Corp (AHCO) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AdaptHealth Corp (AHCO) Forecast

Analysts have given AdaptHealth Corp (AHCO) a Buy based on their latest research and market trends.

According to 6 analysts, AdaptHealth Corp (AHCO) has a Buy consensus rating as of Jul 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AdaptHealth Corp (AHCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.